Rédaction Africa Links 24 with Adajiesther
Published on 2024-04-11 20:30:31
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning to Nigerians regarding the circulation of suspected fake “Tandak Injections” across the country. The agency cautioned healthcare providers and the public against using the counterfeit “TANDAK injection 1.5g powder and water for injection,” which is being sold to unsuspecting individuals. The fake product is purported to be manufactured by Intracin Pharmaceuticals, a human and veterinary health products manufacturer based in Gujarat, India.
Tandak Injection, a combination of Ceftriaxone 100mg and Sulbactam 500mg, is prescribed for the treatment of various bacterial infections in the body, such as gonorrhea, syphilis, urinary tract infections, meningitis, and nosocomial infections caused by susceptible bacteria. It works by inhibiting the spread and growth of microorganisms.
NAFDAC revealed in a statement that the counterfeit product was discovered in Gombe and reported to the agency by “Marcson Healthcare Ltd. – the Marketing Authorization Holder (MAH).” The agency strongly advised against self-prescribing “Ceftriaxone+Sulbactam 1000mg/500mg Injection” and emphasized that it should only be administered under the supervision of a healthcare professional.
In addition to the warning about the fake Tandak Injections, NAFDAC also recalled a children’s cough syrup called Benylin Paediatrics Syrup. The agency’s laboratory analysis identified toxic components in the syrup, prompting the recall. Manufactured by Johnson & Johnson (J&J), Benylin Paediatrics Syrup is used to treat cough, fever, and other allergic conditions in children aged 2 to 12. The presence of a high level of Diethylene glycol, a toxic chemical, was detected in the syrup, which can have fatal effects when ingested. The syrup was found to cause acute oral toxicity in laboratory animals.
NAFDAC urged anyone in possession of the recalled products to discontinue their sale or use and submit them to the nearest NAFDAC office. Healthcare professionals and patients were directed to report any adverse events or side effects related to the use of these products to the agency. NAFDAC’s zonal directors and state coordinators were tasked with conducting surveillance to prevent the circulation of these products in their respective jurisdictions.
The agency emphasized the importance of reporting suspicions of substandard or falsified medicines to the appropriate authorities. Despite law enforcement efforts, the prevalence of substandard products in Nigeria poses a significant health risk to the public, as these products often do not meet regulatory standards, compromising the safety of consumers.
To support credible journalism like this, consider contributing to outlets like PREMIUM TIMES. Your contribution can help sustain relevant journalism and keep it free and available to all. Additionally, reporting suspicions of substandard or falsified medicines is crucial to safeguarding public health. If you encounter any such products, contact the relevant authorities immediately.
Read the original article on Premium Times
